clinical trial · NCT07152210
Clinical Study on the Safety and Preliminary Efficacy of CDH17/GUCY2C CAR-T in the Treatment of Patients With Advanced Colorectal Cancer
Guangzhou Bio-gene Technology Co., Ltd·N/A·recruiting·n = 20
Colorectal Cancer (CRC)CAR-T
brief summary
This study is a single-arm, single-center investigator-initiated trial (IIT) designed to evaluate the safety and preliminary efficacy of CDH17/GUCY2C CAR-T cell therapy in patients with advanced colorectal cancer, as well as to assess its pharmacodynamic (PD) and pharmacokinetic (PK) profiles.
started
Sep 1, 2025
primary completion
Dec 31, 2028
completion
Dec 31, 2028
last updated
Sep 3, 2025
official title
Clinical Study Evaluating the Safety and Preliminary Efficacy of CDH17/GUCY2C CAR-T in the Treatment of Patients With Advanced Colorectal Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol